Chat with us, powered by LiveChat
  Pharmacy CE
ACPE Accredited Continuing Education for Pharmacists and Pharmacy Technicians

Do You Know Your NOACs? Let’s Review the Novel Oral Anticoagulants – 1 CE

Activity Overview

 When it comes to oral anticoagulants, warfarin is no longer the only game in town. The past decade has brought new oral anticoagulant therapy with novel mechanisms of action. Whether practicing in a health system or community setting, understanding the uses, new mechanisms of action, and differences between these new agents is crucial to exceptional patient care.

This activity will review the four novel oral anticoagulants (NOACs): apixaban, dabigatran, edoxaban, and rivaroxaban, and will discuss their mechanism of action, indications, dosing, adverse effects and drug interactions.

The activity will include a review of the anticoagulation cascade with a focus on the place of each drug in the cascade and how they differ from warfarin. Other discussions will include the role of NOACs in the treatment of atrial fibrillation and prevention of deep vein thrombosis and pulmonary embolism based on current CHEST guidelines as well as those developed by the American College of Cardiology, American Heart Association, and European Society of Cardiology. Lastly, the activity will present various counseling points, precautions, and boxed warnings pertinent to patient care

Pharmacist Learning Objectives

At the conclusion of this continuing education activity, the participant will be able to:

  1. Review the mechanisms of action, indications, adverse effects, drug interactions, and counseling points for the four novel oral anticoagulants (NOAC)
  2. Review the anticoagulation cascade and where each NOAC fits based on mechanism of action
  3. Discuss the role of NOACs in the treatment of atrial fibrillation and prevention of venous thromboembolisms based on current treatment guidelines

Pharmacy Technician Learning Objectives

At the conclusion of this continuing education activity, the participant will be able to:

  1. Recognize four novel oral anticoagulants (NOAC)
  2. Discuss indications, dosing, side effects, and drug interactions for each NOAC
  3. Identify precautions and warnings for each NOAC

          BUY NOW

Accreditation Statement

ACPEAchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-799359.

Faculty Information

Rosanna Sutherby, PharmDRosanna Sutherby, PharmD is a freelance medical writer and community pharmacist. She received her PharmD degree from Nova Southeastern University College of Pharmacy in Ft. Lauderdale, FL in 2001. She has been residing and practicing pharmacy in North Carolina since then. Dr. Sutherby’s pharmacy practice has included patient education and medication management for various disease states, including diabetes, cardiovascular disease, mental illness, asthma and pulmonary disease, and pain management. She is a certified immunizer and has worked with a pioneer team of COVID-19 vaccinators in North Carolina. Dr. Sutherby’s published work spans a variety of topics, including cardiovascular health, sleep disorders, mental health, alcohol and opioid use disorders, vaccine education, and medication use and safety.

Financial Support Disclosure

This activity was developed by AchieveCE free of any commercial support.  Rosanna Sutherby, PharmD has no actual or potential conflicts of interest to disclose.

Content Complexity

  Level 2. Basic Application of Skills and Concepts

Delivery Type

Home Study Monograph



1.0 Contact Hour

Target Audience

Pharmacy Technician

Activity Type


Universal Activity Number


Pharmacy Technician:

Activity Release Date

May 3, 2021

Activity Expiration Date

May 3, 2024

Handout Download Link(s)



Requirements for Credit

Participants must score a passing grade of 70% or higher on the activity post-test and complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CPE Monitor and/or CE Broker if your license information is entered properly in your profile.

Hardware Requirements

Windows 8.1, Windows 10
Mac OS X 10.1 or higher
iOS 10+, Android 4.3+

Software Requirements

Google Chrome, Microsoft Edge, Mozilla Firefox
Adobe Acrobat Reader

Network Requirements

Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection

Ready to Start?

          BUY NOW

You may also be interested in:

Direct Oral Anticoagulation Therapy Bleeding Risks and Emerging Reversal Agents Options – 2 CE

Each direct-acting oral anticoagulants agent has a unique pharmacokinetic profile and approved indication, therefore, educational initiatives are esse...


Current Antibiotic Treatment Guidelines: A Guide for Pharmacy Professionals – 0.25 CE

With the rise in antibiotic-resistant bacteria, it is imperative that prescribers and pharmacy professionals practice good antibiotic stewardship to e...


Who Do You Think You Are? Learning More About Emotional Intelligence – 1 CE

As the interpersonal demands of pharmacy practice continue to increase, pharmacists need to better understand themselves and the way they are perceive...